ENDRA Life Sciences Inc. (NDRA)
After hours:
- Business Wire
ENDRA Life Sciences Announces Pricing of $8.0 Million Public Offering
ANN ARBOR, Mich., June 04, 2024--ENDRA Life Sciences Inc. (Nasdaq: NDRA) ("ENDRA" or the "Company"), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), announced today that it has priced a public offering with gross proceeds to the Company expected to be approximately $8.0 million, before deducting placement agent fees and other estimated expenses payable by the Company. The offering is a best-efforts offering, with no minimum amount of securities required to be sold.
- Business Wire
ENDRA Provides Update Following In-person Meeting with FDA
ANN ARBOR, Mich., May 20, 2024--ENDRA Life Sciences Inc. (NASDAQ: NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), announced that it has completed what it considers to be a highly informative pre-submission meeting with the U.S. Food and Drug Administration (FDA) related to the clinical trial design of the TAEUS liver device in support of its U.S. De Novo filing.
- GuruFocus.com
ENDRA Life Sciences Inc (NDRA) (Q1 2024) Earnings Call Transcript Highlights: Strategic ...
Discover how ENDRA Life Sciences Inc navigates its financial landscape and strategic milestones amidst ongoing challenges.
